![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comparison of Long-Acting Lenacapavir Phase 2/3 Regimen vs Simplified Regimen Using Population-PK Analysis and Simulation
|
|
|
IAS 2023 july 25
Naveed A. Shaik,1 Francesco Bellanti,2 Kishore Pollireddy,2 Vamshi Jogiraju,1 Craig Comisar,2 Sandhya Girish,1 Martin Rhee,1 Ramesh Palaparthy,1 Renu Singh1
1Gilead Sciences, Inc., Foster City, California, USA; 2Certara, Inc., Princeton, New Jersey, USA
![0726231](../images/072623/072623-6/0726231.gif)
![0726232](../images/072623/072623-6/0726232.gif)
![0726233](../images/072623/072623-6/0726233.gif)
![0726234](../images/072623/072623-6/0726234.gif)
![0726235](../images/072623/072623-6/0726235.gif)
![0726236](../images/072623/072623-6/0726236.gif)
![0726237](../images/072623/072623-6/0726237.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|